Kiritsy Christopher P
- SEC CIK
- 0001261156
In the past year, 1 open-market sale filing worth $49.1K and no purchases.
Current role at each company
- PVLA Palvella Therapeutics, Inc.Directoras of Sep 4, 2026
- HTGM HTG Molecular Diagnostics, IncDirectoras of Sep 15, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $49.1K
- 1 filing
- Net
- −$49.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kiritsy Christopher P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PVLA Palvella Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 (view filing)4:05 PM ET | Sep 2 | 2 days | Kiritsy Christopher PDirector | SSale | −313 | $157.00 | −$49.1K | −55.6%250 after | |
| May 30, 2023 (view filing) | May 25 | 5 days | Kiritsy Christopher PDirector | PPurchase | +10.0K | $0.85 | +$8.50K | +100.0%20.0K after |